DFWIX
Price
$19.41
Change
+$0.08 (+0.41%)
Updated
Jun 2 closing price
Net Assets
5.58B
VTIAX
Price
$46.73
Change
+$0.28 (+0.60%)
Updated
Jun 2 closing price
Net Assets
629.15B
Interact to see
Advertisement

DFWIX vs VTIAX

Header iconDFWIX vs VTIAX Comparison
Open Charts DFWIX vs VTIAXBanner chart's image
DFWIX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
DFWIX vs. VTIAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFWIX is a Buy and VTIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 629B vs. DFWIX (5.58B). DFWIX pays higher dividends than VTIAX: DFWIX (2.81) vs VTIAX (2.63). DFWIX was incepted earlier than VTIAX: DFWIX (13 years) vs VTIAX (16 years). DFWIX (0.30) is less costly to investors than VTIAX (0.09). DFWIX is a more actively managed with annual turnover of: 8.00 vs. VTIAX (4.00). DFWIX has a lower initial minimum investment than VTIAX: DFWIX (0) vs VTIAX (3000). DFWIX annual gain was more profitable for investors over the last year : 33.17 vs. VTIAX (30.41). DFWIX return over 5 years is better than : 55.03 vs. VTIAX (34.92).
DFWIXVTIAXDFWIX / VTIAX
Total Expense Ratio0.300.09333%
Annual Report Gross Expense Ratio0.300.09333%
Fund Existence13 years16 years-
Gain YTD14.95115.34297%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.58B629B1%
Annual Yield % from dividends2.812.63107%
Returns for 1 year33.1730.41109%
Returns for 3 years74.3960.44123%
Returns for 5 years55.0334.92158%
Returns for 10 years140.52105.63133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPEN5.410.10
+1.88%
Opendoor Technologies
SBR77.141.28
+1.69%
Sabine Royalty Trust
WBD27.17-0.08
-0.29%
Warner Bros Discovery
HELP4.55-0.14
-2.99%
Cybin Inc
CLRB2.76-0.22
-7.24%
Cellectar Biosciences Inc